BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang L, Chen L, Li D, Xu H, Chen J, Min X, He M, Wu T, Zhong J, Yang H, Chen J. Effect of GLP-1/GLP-1R on the Polarization of Macrophages in the Occurrence and Development of Atherosclerosis. Mediators Inflamm 2021;2021:5568159. [PMID: 33854404 DOI: 10.1155/2021/5568159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Biesenbach IIA, Heinsen LJ, Overgaard KS, Andersen TR, Auscher S, Egstrup K. The Effect of Clinically Indicated Liraglutide on Pericoronary Adipose Tissue in Type 2 Diabetic Patients. Cardiovasc Ther 2023;2023:5126825. [PMID: 36714196 DOI: 10.1155/2023/5126825] [Reference Citation Analysis]
2 Chen J, Mei A, Wei Y, Li C, Qian H, Min X, Yang H, Dong L, Rao X, Zhong J. GLP-1 receptor agonist as a modulator of innate immunity. Front Immunol 2022;13:997578. [PMID: 36569936 DOI: 10.3389/fimmu.2022.997578] [Reference Citation Analysis]
3 Xue CY, Zhou MQ, Zheng QY, Zhang JH, Cheng WT, Bai XH, Zhou F, Wu AM, Nie B, Liu WJ, Lou LX. Thiazolidinediones play a positive role in the vascular endothelium and inhibit plaque progression in diabetic patients with coronary atherosclerosis: A systematic review and meta-analysis. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1043406] [Reference Citation Analysis]
4 Shao S, Zhang X, Xu Q, Pan R, Chen Y. Emerging roles of Glucagon like peptide-1 in the management of autoimmune diseases and diabetes-associated comorbidities. Pharmacology & Therapeutics 2022;239:108270. [DOI: 10.1016/j.pharmthera.2022.108270] [Reference Citation Analysis]
5 Song L, Zhang J, Ma D, Fan Y, Lai R, Tian W, Zhang Z, Ju J, Xu H. A Bibliometric and Knowledge-Map Analysis of Macrophage Polarization in Atherosclerosis From 2001 to 2021. Front Immunol 2022;13:910444. [DOI: 10.3389/fimmu.2022.910444] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Galatou E, Mourelatou E, Hatziantoniou S, Vizirianakis IS. Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs. Antioxidants 2022;11:1060. [DOI: 10.3390/antiox11061060] [Reference Citation Analysis]
7 Diaz-Jimenez D, Kolb JP, Cidlowski JA. Glucocorticoids as Regulators of Macrophage-Mediated Tissue Homeostasis. Front Immunol 2021;12:669891. [PMID: 34079551 DOI: 10.3389/fimmu.2021.669891] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
8 Ma X, Liu Z, Ilyas I, Little PJ, Kamato D, Sahebka A, Chen Z, Luo S, Zheng X, Weng J, Xu S. GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential. Int J Biol Sci 2021;17:2050-68. [PMID: 34131405 DOI: 10.7150/ijbs.59965] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 8.5] [Reference Citation Analysis]